Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Morton

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Physiological Measurement|October 10, 2015
In vitro validation of endovascular Doppler-derived flow rates in models of the cerebral circulationP M McGah, J D Nerva, R P Morton, et al.
Australasian Radiology|April 26, 2006
TN/TN glottic carcinoma: a comparison of two fractionation schedulesS Short, H Krawitz, A Macann, et al.
AJNR. American Journal of Neuroradiology|July 23, 2013
Cerebral aneurysms treated with flow-diverting stents: computational models with intravascular blood flow measurementsM R Levitt, P M McGah, A Aliseda, et al.
Clinical Otolaryngology and Allied Sciences|June 1, 1987
Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinumJ B Campbell, E B Dorman, T R Helliwell, et al.
Acta Oto-Laryngologica|May 1, 1987
A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancerJ B Campbell, E B Dorman, M McCormick, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life GroupK Bjordal, A de Graeff, P M Fayers, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Physiological Measurement|October 10, 2015
In vitro validation of endovascular Doppler-derived flow rates in models of the cerebral circulationP M McGah, J D Nerva, R P Morton, et al.
Australasian Radiology|April 26, 2006
TN/TN glottic carcinoma: a comparison of two fractionation schedulesS Short, H Krawitz, A Macann, et al.
AJNR. American Journal of Neuroradiology|July 23, 2013
Cerebral aneurysms treated with flow-diverting stents: computational models with intravascular blood flow measurementsM R Levitt, P M McGah, A Aliseda, et al.
Clinical Otolaryngology and Allied Sciences|June 1, 1987
Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinumJ B Campbell, E B Dorman, T R Helliwell, et al.
Acta Oto-Laryngologica|May 1, 1987
A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancerJ B Campbell, E B Dorman, M McCormick, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life GroupK Bjordal, A de Graeff, P M Fayers, et al.
Pageof 10